Drug Topics

JANUARY 7, 2025

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Vaccines 210

Vaccines Immunization 210

Pharmacy Times

JANUARY 7, 2025

Despite these concerns, experts have emphasized that the benefits of RSV vaccination outweigh potential risks for older adults, who are at heightened risk of severe RSV-related illness.

Vaccines 132

Vaccines FDA 132

Drug Topics

JANUARY 7, 2025

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

Hospitals 186

Hospitals 186

Pharmacy Times

JANUARY 7, 2025

AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.

122

122

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JANUARY 7, 2025

One year after announcing a new maternal health model for women in Medicaid, the Centers for Medicare & Medicaid Services announced the participating states.

114

114

Pharmacy Times

JANUARY 7, 2025

Approximately 61% of individuals said respiratory syncytial virus (RSV vaccination for adults 60 years and older is effective.

Vaccines 121

Vaccines 121

STAT

JANUARY 7, 2025

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

Documentation 127

Documentation Insurance FDA 127

European Pharmaceutical Review

JANUARY 7, 2025

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

FDA 98

FDA Patient Care 98

pharmaphorum

JANUARY 7, 2025

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

105

105

Drug Topics

JANUARY 7, 2025

David Nau, PhD, discusses how more graduating pharmacy students say they would choose pharmacy again if starting college over.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 7, 2025

Top of the morning to you, and a fine one it is, although we concede this may depend on your tolerance for frigid temperatures. Nonetheless, blue skies and a shiny sun are enveloping the Pharmalot campus, where the official mascots are hunting wildlife and we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today, hazelnut mocha) and foraging for items of interest.

FDA 88

FDA Compounding Documentation 88

pharmaphorum

JANUARY 7, 2025

A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.

93

93

The Guardian - Pharmaceutical Industry

JANUARY 7, 2025

Medical advances make pills to treat Alzheimers disease viable, though challenges remain in sharing gains globally Pills that prevent Alzheimers disease or blunt its effects are on the horizon, as the fight against dementia enters a new era, experts have said. Scientific advances were on the cusp of producing medicines that could be used even in the most remote and under-resourced parts of the world, thereby democratising care, said Jeff Cummings, professor of brain science and health at the Uni

91

91

pharmaphorum

JANUARY 7, 2025

GSK has claimed its second breakthrough designation from the FDA for B7-H3-targeted ADC, this time in osteosarcoma.

FDA 91

FDA 91

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Outsourcing Pharma

JANUARY 7, 2025

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future analysis.

88

88

Pharmacy Times

JANUARY 7, 2025

Age, frequent snoring, hypertension, and poor glycemic control are associated with excessive daytime sleepiness.

81

81

The Checkup by Singlecare

JANUARY 7, 2025

A staple in American pantries, oats have been around for tens of thousands of years. The oat is a species of cereal grain native to parts of Asia and Europe, though dozens of countries worldwide grow and distribute oats today. While there are many ways to use oats, none are as popular as a warm, hearty bowl of oatmeal or porridge. Oatmeal is a cost-effective, accessible, and versatile breakfast option.

Compounding 72

Compounding 72

Pharmacy Times

JANUARY 7, 2025

These inequalities, which can include socioeconomic disparities, show neurological changes associated with aging and dementia.

81

81

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 7, 2025

The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area

FDA 64

FDA 64

Pharmacy Times

JANUARY 7, 2025

COVID-19 survivors deemed the most highly impacted and fearful also reported the lowest health-related quality of life scores, indicating an association.

73

73

Fierce Healthcare

JANUARY 7, 2025

Sanford Health finalized its merger with Marshfield Clinic Health System, the health systems announced last week, and the deal expands Sanford's reach to communities in Wisconsin and Michigans Upper Peninsula.

63

63

Pharmacy Times

JANUARY 7, 2025

A pooled analysis showed regular consumption of coffee and tea was associated with decreased risk of certain cancers.

73

73

pharmaphorum

JANUARY 7, 2025

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI).

59

59

Pharmacy Times

JANUARY 7, 2025

Bortezomib for Injection is a proteasome inhibitor indicated for treatment of adult patients with multiple myeloma and treatment of adult patients with mantle cell lymphoma.

65

65

PharmaVoice

JANUARY 7, 2025

New formulations for under-the-skin application of drugs give pharmas another opening in a crowded market.

59

59

Pharmacy Times

JANUARY 7, 2025

The tablets are indicated for treatment of adults with chronic idiopathic constipation, with further research needed to assess efficacy and safety in children.

65

65

Pharmaceutical Technology

JANUARY 7, 2025

Variant has entered a multi-year research partnership with Novo Nordisk to identify new targets to treat metabolic conditions.

59

59

Pharmacy Times

JANUARY 7, 2025

Management of acute otitis media in children involves evidence-based antibiotic prescribing.

65

65

Pharmaceutical Technology

JANUARY 7, 2025

The FDA has accepted for filing and priority review Sentynl Therapeutics CUTX-101 NDA for the treatment of Menkes disease.

FDA 59

FDA 59

Pharmacy Times

JANUARY 7, 2025

Sunvozertinib was originally approved in China, making it the worlds first and only oral treatment for these patients.

FDA 65

FDA 65

Pharmaceutical Technology

JANUARY 7, 2025

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

Vaccines 59

Vaccines 59

Fierce Healthcare

JANUARY 7, 2025

Twentyeight Health, a digital-first womens healthcare provider, picked up $10 million in series A funding and inked new payer partnerships with Medicaid insurers Aetna, AmeriHealth Caritas and Molina Healthcare.

Insurance 58

Insurance 58

Pharmaceutical Technology

JANUARY 7, 2025

Candid plans to conduct first-in-human studies in 2026 as it continues its T-cell engager deal drive.

59

59